Background: Pain is a frequently reported symptom by patients approaching the end of life and wellestablished that patients and carers hold fears relating to opioids, and experience side effects related to their use. The management of medicines is intrinsic to achieving effective pain relief. The concept of self-management support whilst well characterised in the context of chronic illness has not been elaborated with respect to end of life care. Aim: To identify patient, carer and professional views on the concept of self-management support at end of life, specifically in relation to analgesia and related medicines (for side-effect management) in order to describe, characterise and explain self-management support in this context.
WHAT IS ALREADY KNOWN ABOUT THE TOPIC?
 Pain is a frequently reported symptom by patients who are approaching the end of their lives.  It is well-established patients and carers hold fears that relate to opioids, and experience side effects related to their use.  The concept of self-management support is well elaborated in the context of chronic illness  Through the technique of concept analysis Johnston and colleagues (2014) have defined the concept of self-management support from a palliative nursing perspective and outlined the range roles adopted by nurses to support self-management.  How self-management is operationalized in the practice context at the end of life remains little understood WHAT THIS PAPER ADDS  An empirically grounded description of self-management support at end of life, in the context of analgesia management from the perspective of patients, carers and healthcare professionals.  Characterisation of the roles undertaken by patients, carers and clinical nurse specialists to support opioid management and how these roles are enacted in the context of specialist palliative care.  Demonstration of the salience of the concept of self-management support as the end of life approaches.
INTRODUCTION
Self-management support has been well elaborated and tested, and programmes of support offered in the context of chronic illness (Taylor et al 2014) . In contrast, in the situation where someone is rapidly approaching the end of life there is much less evidence of if and how this concept applies . Johnston is one of a handful of authors to have addressed this, who along with colleagues (2009; 2012) , argued that benefits of self-management focused symptom control include improved health status, reduced hospital admission, reduced pain and symptom distress, and can result in people feeling in more control with respect to pain and more prepared for end of life. Through recourse to concept analysis self-management support in palliative nursing has been defined as: assessing, planning, and implementing appropriate care to enable the patient to live until they die and supporting the patient to be given the means to master or deal with their illness or their (Johnston et al 2014, p8) . Eight professional nursing roles that support self-management: advocate, educator, facilitator, problem solver, communicator, goal setter, monitor and reporter were outlined. Whilst these nursing roles were depicted they were neither described nor characterised and little is understood about how they are operationalised in the context of practice. Hence there is a lack of knowledge about self-management support in the context of end of life care with little evidence with which to underpin practice.
In one of the only studies in this area, Schumacher and colleagues in the US (2014a&b) have studied the self-management work that goes on in relation to pain medication management in cancer patients. Their research revealed that much of what goes on involves work that is challenging and frustrating for patients and could be alleviated by better information, skills and health services co-ordination to support patient self-management. The work of getting prescriptions, obtaining medications, understanding, organising, storing, scheduling, remembering, and taking was perceived to be unending and required a huge amount of effort in order to navigate healthcare systems and often resulted in frustration and anxiety. As the sample consisted of oncology out-patients whether these findings might transfer to the specific context of end of life care was not clear.
Given there is limited understanding of if and how the concept of self-management support might be applied in the context of end of life care we set out to investigate the concept further, exploring its application through accessing the perspectives of patients, carers and health professionals. We defined carers as anyone who cared, unpaid, for a friend or family member due to their end of life illness.
AIMS/OBJECTIVES
The study aimed to describe, characterise and understand the concept of self-management support as the end of life approaches, in the specific context of managing analgesia and related treatments. This work formed part of a larger study involving intervention design and a feasibility trial of selfmanagement support in relation to opioid medications for pain relief, and the associated side-effects of nausea, constipation and drowsiness at the end of life .
The objectives were to:  Characterise the nature of self-management support regarding analgesia and related treatments at the end of life  Explore in-depth the views of patients, carers and healthcare professionals regarding the components of self-management support in this context  Reveal self-management promoting behaviours and roles used by patients, carers and healthcare professionals
METHODOLOGY & METHODS Study design
A qualitative approach was used and data collection comprised focus groups and interviews, held within two geographical regions in England (one North and the other South).
Participants
Participants included patients, their carers and specialist, largely community based, palliative care health professionals (including service managers and commissioners).
Sampling Strategy and Recruitment

Inclusion criteria
Patients were included if they were: 1. Aged over 25 and considered (by their specialist palliative care team) to be in the last year of life 2. Experiencing pain 3. Being treated with, or starting, opioid analgesia 4. Experiencing, or anticipating, adverse effects of nausea, constipation and drowsiness 5. Living at home 6. Being cared for by specialist community based palliative care services in the 2 study regions 7. Had capacity to consent Carers were included if they were:
1. The primary carer of a patient meeting the above inclusion criteria 2. And, the patient gave consent to their involvement Healthcare professionals were included if they were: 1. Clinical Nurse Specialists (CNSs) or doctors who were part of specialist palliative care teams or 2. Service providers or managers of specialist palliative care services or 3. Local commissioners of palliative care services
In order to access a range of individuals (patients, carers and healthcare professionals) recruitment occurred via various strategies across four hospices and two acute Trusts. In the Southern region palliative care specialist healthcare professionals at two acute Trusts and two hospices were informed about the study via staff meetings attended by a researcher (NC), supplemented by email invitations, and invited to participate in a focus group. Patients and carers attending group sessions at two day hospices in the region were informed about the study by a researcher (NC) and able to ask questions about participation; all specified a preference for taking part in interviews (rather than a focus group). In the Northern region a community palliative care CNS team were invited (by MM) to take part in a focus group; and patients and carers were approached by a research nurse via the out-patient clinic at the respective hospice, and invited to a focus group.
Focus Group and Interview Guides
Topic/interview guides were developed to meet the study aims. Largely semi-structured, interview topics included: self-management of analgesia and related side-effects of nausea, constipation and drowsiness; roles played in managing medicines; processes involved in accessing, obtaining and understanding medicines in order to safely store, organise and take them. Guides were constructed and materials used to explore and elaborate on the following concepts:
 Definition of self-management support in the context of palliative care (Johnston et al 2014)  Professional roles adopted in support of self-management in the context of palliative care (Johnston et al 2014)  Processes involved in managing supply and medicines-taking encountered by patients and carers (Schumacher et al 2014a (Schumacher et al & 2014b I MM NC Focus groups took place W in interviews all patients expressed a wish to be interviewed with their carer (dyadic interviews). After obtaining informed consent all interviews and focus groups were digitally-recorded. Focus groups were conducted with a co-facilitator present, in this case another researcher with expertise in the field, to aid moderation (Krueger & Casey 2014) .
Data Analysis
Audio files from the interviews and focus groups were professionally transcribed and listened to alongside the transcripts to check for accuracy. Researchers (NC, MM) familiarised themselves with data by reading and re-reading the transcripts and identifying key issues, concepts and themes. Initial coding occurred via indexing on the transcripts and each researcher summarised key themes arising from the data separately. Themes were subsequently discussed for comparative purposes. The entire dataset was then coded for all issues, aspects and themes relevant to self-management support (NC) within NVivo software (version 11). A deductive-driven approach was used, verifying and validating key frameworks from the literature, but with capacity for new findings to emerge 
FINDINGS
The sample comprised 38 participants recruited across the two regions: 15 patients, 4 carers and 19 healthcare professionals (Table 1) . The findings are presented in two discrete sections. The first section characterises the range of self-management and self-management support roles adopted by patients, carers and nurse specialists as they relate to pain medicine management. Secondly, these data are incorporated into a model of self-management support, alongside a description of the continuum of self-management behaviours in the context of the end of life.
Self-Management and Self-Management Support Roles
Data supported the eight roles proposed by Johnston et al (2014) and furthered understanding by revealing the roles were not confined solely to nurses (see Table 2 ). Patients, carers and CNSs enacted these roles in various ways ( Table 2 ).
The labels used by Johnston et al (2014) to refer to roles were presented to healthcare professionals during the focus groups. They were asked for their views on these roles, whether they believed they occurred in practice, if anything was missing and what examples they could provide to illustrate the roles in action. As a result the roles were both delineated and defined by the professionals in this study. These were generated from accounts involving a preponderance of community-based healthcare professionals, but it could be argued the roles could equally apply to those in other practice settings.
Descriptions from patients and carers confirmed the range and types of roles adopted and the part (and medication for nausea and constipation). The roles that patients and carers took on could be categorised in the same way as those undertaken by CNSs, but often implemented and enacted in different ways. Some patients in the study managed their medicines almost entirely by themselves, however this occurred only for a minority. Where patients had visits from a palliative care nurse specialist they highlighted the importance and value of their nurse input in relation to medicines F I answers H P The self-management support roles of carers fluctuated in relation to changes in the competence and engagement of the patient. Some patients leant on their carers very little even where they were h I C -H1Pt002), but again this was confined to the minority. In the case of a few patients they had always sought to hand over I not I (H1Pt004).
To evaluate which roles were required of them, and at what point, nurses assessed the competence of not only the patient but also the carer. It was recognised that self-management support roles would fluctuate in relation to patient and carer needs and, at times, be challenging to undertake.
A A H HCP
Advocate
Patients often played an advocacy role on their own behalf, for example requesting alternative analgesics/opioids where they found side-effects to be unacceptable and were unable to manage these. Where advocating on their own behalf was not possible carers took on this role for patients, especially when difficulties arose with challenging side-effects or poorly controlled pain.
He was determined to get me into the hospice, and in the end he went over himself. And I " X I and have a (H2Pt001)
Nurses emphasised the importance of ensuring patients had the right drug, via the right route. For them this was a clear example of the advocacy role:
I ompromising her mouth and she
Educator
Patients educated their carer, if they had one, regarding their medicines so if their condition changed or they had a bad day they could rely on them to safely administer their medications for them. This often took the form of listing their medications and creating a simple timetable of what they took and when, and keeping this in a location in the home that could be easily referred to by others if needed. Equally, carers could play an educator role of both the patient and CNS via astute monitoring of sideeffects and the effectiveness of medicines, highlighting changes.
The role of educator was viewed by nurses as one that involved providing (H2HCPfocusgroup) to patients and carers. This was valued strongly by patients:
is not working I so helpful. That was the first time that I I I
The increasing role of the internet as a source of information for patients and their families was also recognised so that the supportive role of nurses was seen as one of h refine and apply this knowledge to individuals. The need to provide education for carers specifically was recognised to be important as many had unmet information needs and knowledge gaps: 
Goal-setting
For those patients who were under the care of community palliative care CNSs this often involved developing joint plans /goals with them. Whereas patients not under the care of a CNS made their own plans and goals, and/or negotiated these with their general practitioner (for example coming off a neuropathic agent because of unacceptable side-effects).
Carers often took a lead in establishing small goals for a patient when they aware these were of particular importance to the individual. With effective medicines management and particularly sideeffect management, frequently goals involved getting out and about, and visiting favourite places.
With respect to professional involvement in goal-setting this would often involve proposing different options to a patient in relation to their medicines management, allowing an individual to decide between different proposed courses of action and then putting a joint plan together based on an .
I we could do this, which would you like to try? That i (H3Ptfocusgroup)
Facilitator
Patients facilitated relationships with their healthcare professionals and carers so as to aid access to their medicines. Patients worked at developing and maintaining relationships with those that were key to managing their medicines and supporting their self-management. Generally this involved CNSs and general practitioners but also community pharmacists. They often found that knowing their pharmacist, and the pharmacist knowing them, aided the supply and stocking of their medicines, and affected their ability to obtain their medicines quickly and without delays in the system. At times pharmacists put in repeat prescription requests for patients because of these relationships, meaning a patient then just had to arrange to collect the medications from the pharmacy or they could use the pharmacy delivery services, where they were available.
The role of specifically facilitating/managing the practical issues related to supply and medicinestaking was frequently an onerous one for patients. They had to get prescriptions, obtain the medicines, understand them once they had been dispensed, organise the medicines at home to keep track of them, store them, schedule them around their routine, remember to take them and finally actually administer them.
I ve had C GP N for it (repeat supply), either prescribing it to the Chemist and then the Chemist gives it to me,
I A
The implications of the supply system and the requirements for organising, storing, scheduling, remembering and administering were very significant in patient and carer accounts and Table 3 summarises the effects and impact of these issues (Table 3) .
Carers facilitated the supply system by managing all the practical issues of: getting prescriptions, obtaining the medicines, understanding the medicines, organising the medicines in the home remembering (i.e. reminding the individual to take the medicines) and administering medicines if required (Table 3) :
I have a friend who does my patches for me. And between us, there is both of us to
Facilitating on behalf of the patient in relation to obtaining medicines was complex, onerous and a hugely time-consuming process for many carers. Carers also pre-emptively facilitated stock management, requesting medicines before they ran out, and chased both GP practices for prescriptions and pharmacies if medications had not been dispensed as requested.
One patient outlined his difficulties (lengthy delays) in obtaining supplies of his fentanyl patches through a non-palliative care specialist pharmacy.
When I rang through (to the pharmacy)
This left his wife needing to make in person visits to the pharmacy, striving to facilitate supply on his behalf, only for her to be equally frustrated and leave without the patches in tears because she could s prescribed this (Carer-H2Pt004).
Nurses also acted as facilitators in relation to the practical issues of getting prescriptions, obtaining the medicines, organising the medicines at home, storing the medicines safely and scheduling the medicines around their daily routines (Table 3 ). For example:
G I a youngish intelligent chap and he has just really struggled with that. I think the other issue is sometimes they get 28 tablets and then you (H1HCPfocusgroup)
This was out of sync with alterations in a prescription. For example, doubling a dose then meant that supplies lasted for much shorter periods of time and ran out in advance of supplies of other medications.
Problem-Solver
Patients played a problem-solving role, often striving to navigate the difficulties posed by the medicines supply system. They also problem-solved the side-effects of their opioids making decisions to appropriately balance the benefits of pain control vs. a manageable level of side-effects for them personally. This was always a balance, for example titrating laxatives or anti-emetics on a daily basis to offset the common side-effects. Some individuals, whilst in the minority, made decisions regarding which dose of opioid to take, where a range has been prescribed from which they could choose.
The role of carer in relation to problem-I I try and stop problems happening C -H2Pt004). This was in the main pre-emptive, resolving potential problems before they arose. This was particularly the case in terms of asking an individual about their Within their problem-solving role nurses sought to work out the best drug and dosage with the most tolerable side-effect profile for an individual, recognising that this necessitated fine-tuning over time, time which was by its very nature limited at the end of life. This problem-solving role was frequently implemented in a pre-emptive way, and mind-reading a problem solver in advance a plan B when and who to contact or the likelihood of a particular individual experiencing a crisis episode e.g. chest inflections or bowel obstruction and conveying information to support patient and carer recognition).
Y
-empting what might happen to be able to talk it through with that patient and to that carer to be able to give them you know a toolkit of who to ring, when to ring and why they might ring. How to deal with the uncertainties of do I ring now, do I (H1HCPfocusgroup)
Monitor
Patients monitored their symptoms, side-effects and the effectiveness of their medicines, often for breakthrough pain. This was often facilitated through the input of community palliative care CNSs or how much they were taking, when they were taking it, and how did they find it? H HCP oup).
Carers often played a monitoring role highlighting and watching for condition changes, symptom changes and alterations in side-effect management. Indeed, the monitoring they undertook was often extremely astute due to the fact they were the person who knew the patient best.
The CNS role of monitor was closely related in practice with the role of goal setter (involvement in decision-making and shared responsibility where possible). N how much the patient has understood
This monitoring role was seen as an imperative professional responsibility, particularly when starting individuals on new medications. This led nurses to frequently contact patients, either face to face or on the phone, often within 24 hours of starting a new drug. Nurses emphasised the value of face-toface monitoring in the context of end of life. In the words of one:
I H managing, then you actually go back and reassess them face-to-face; there is nothing quite (HCPW001)
Reporter As a result of the monitoring role patients undertook they were often in a position to accurately report their relevant symptom and side-effect experiences, and changes, to their healthcare professionals. Carers often aided monitoring of the effectiveness of the medicines by asking simple questions such I D Consequently, carers encouraged discussion with the patient (within their communicator role) and could report this information to healthcare professionals. In addition, CNSs often relayed and discussed goal-setting plans with the wider palliative care team and general practitioners (to support medication changes) under the role of reporter.
Continuum of Self-Management Behaviours
Further inductive analysis led us to generate a model of self-management support pertinent to the end of life context (Figure 1 ). Self-management support was conceived as a dynamic process, enacted through a continuum of behaviours and depended on the specific responsibilities and roles adopted by patients, carers and specialist nurses. This is context specific (end of life) and influenced by opioid-related fears.
At the centre of the model (Figure 1 ) is a continuum of behaviours that ranged from:  Full engagement -with full responsibility chosen by an individual, with acceptance of the possibility of risk and requirements for complex decision-making, through to  No Engagement -with reduced capabilities and willingness to engage in self-management behaviours, for example through individual choice (preference), the effects of uncontrolled pain, the side-effects of opioids (particularly drowsiness), clinical depression and memory loss, all of which lead to responsibilities being transferred to another (the carer and/or CNS) Study participants highlighted variation in the range of self-management behaviours enacted. Y
want to H HCP
Asking them to go verything (H4HCPfocusgroup)
When discussing the role played in managing their medicines those who felt in control, often lucky think about it and work it out These individuals accepted and preferred full doing it all backup strategies in place and knowledge of whom to contact should issues arise.
Healthcare professionals often spoke about individuals who were at polar ends of the continuum, but there was also evidence of wide intra-person variation in both behaviours and choices and these could and did continually fluctuate:
A H
lots of " not adequately in our eyes, but he is doing what he wants to do at the m
The degree of competency and degree of engagement in tasks involved, and preference in regard to accepting responsibility affected enactment of self-management behaviours, and subsequently influenced the roles adopted by carers and CNSs. Nurses recognised the importance of assessing an and their potential for engagement (what the individual was currently doing vs. what they would like and had capacity to do).
End of Life Context
The fact patients were approaching the very end of their lives had a profound influence on the supportive self-management behaviours of patients, carer and CNSs. Continual disease progression led to rapid changes in symptoms and side-effects experienced from medication and treatment. This in turn led to fluctuations in behaviours. This context was overlaid with individuals and their families striving to deal with the psychological distress and high levels of carer strain that can accompany terminal decline. Patients were reluctant to take opioids for fear of both constipation and drowsiness. The fear of constipation and subsequent difficulties in balancing doses of laxatives with opioid intake was particularly troublesome for some. Some had experienced faecal impaction requiring hospice admission; as a result the fear of constipation was profound. 
DISCUSSION
The majority of end-of-life care takes place in the home, being undertaken by patients and carers and supported by health care professionals, often nurses. Effective management of medicines in this context is critical for symptom control, quality of life, avoidance of unplanned and emergency services and hospital admission. Equipping and supporting patients and carers to self-manage this important task is a key nursing responsibility. Yet little was known about how self-management is enacted in the home setting at the end of life. To our knowledge, this is the first UK study to characterise selfmanagement and how it is supported in this context, providing a valuable understanding of the work and roles that patients and carers undertake and how nurses can and do support this.
Our findings highlight the variety of roles that nurses enact to support patients and carers selfmanaging medicines, and they confirm and embellish the role typology proposed by Johnston et al (2012) . Additionally, we also discovered that patients and carers may assume these roles in pursuit of self-managing medicines, albeit with slightly different foci than that taken by the nurses. For example, the need to sometimes act as advocate, facilitator and reporter was common to all actors in this context. This also highlights the significant work that patients and carers were found to be undertaking in order to effectively self-manage. Similar to the context of long-term conditions (see , self-management here did not comprise patients and carers managing with complete autonomy however, but required a blend of autonomy balanced with input and support from health care professionals. The finding that self-management support in the end-of-life context involves the provision of information and education also chimes with key factors identified as necessary for self-management in other contexts (Taylor et al 2014) .
The idea of self-management being a dynamic process, with shifts in patient preference for taking responsibility versus being a more passive recipient of care is not new. Brearley (1990) first proposed that patient participation in care will vary according to factors including acuity of illness and age. Protheroe et al (2008) also found that patients with long-term conditions need information for selfmanagement at different stages in their illness trajectory and in a variety of formats, depending on the receptivity of the patient. However, what our findings indicate is that this inter-and intra-personal fluctuation also exists in the end of life context, and indeed is compressed and magnified due to the complex context in which self-management is enacted and supported. The end of life context, characterised by often rapid -effects and opioid-related fears, all contributed to the existence of a continuum of self-management behaviours ranging from full to limited or no engagement, and rapid changes in patient and carer competencies in, and preferences for, self-management. This is in contrast to long-term conditions such as diabetes or asthma, which, if well controlled, offer more stable conditions for supporting selfmanagement over a longer period of time.
The study findings illustrate that effective nursing support for self-management in this context requires highly skilled, individualised and on-going assessment of patient and carer needs to detect changes in competencies and preferences for engagement and responsibility. Nurses must also adapt and assume roles that shift and complement these changing patient and carer competencies and preferences. The salience of opioid-related fears, in addition to frequent changes in medicines and polypharmacy, means that a key feature of self-management support is provision of information and education to allay fears, change m side-effects. Together with experiences from previous research (Latter et al, under review) , we used our identification of these central components of self-management support (assessment and education), along with goal-setting, monitoring and coaching to form the basis of an end-of-life analgesia and related treatments self-management support intervention delivered by nurses and tested in a feasibility trial (see Bennett et al 2016) .
Finally, our findings identify the often-problematic issues experiences of medicines supply and medicines-taking. O " s (2014 a&b) study that these processes exist in a UK context and are typically characterised by effort and burden for the patient and carer. Additionally, we suggest that many of the problems -such as those described in getting and obtaining medicines in Table 3 -are due to system or service organisation failure. For example, the dearth of nurse prescribing in palliative care has been noted elsewhere (Zeigler et al, under review) and appears to contribute to patients access to medicines. Community pharmacy services might also require improvement, and new services in the UK such as community pharmacist palliative care medicines access services may be important in redressing the problems patients and carers experienced in our study. Further research is needed into patient and carer experience of accessing medicines in the end-of-life context.
CONCLUSION:
Our study has demonstrated for the first time what self-management support at end of life entails and how it is enacted in practice, in relation to analgesia and related treatments. The concept has highlighted the importance for specialist nurses of recognising the roles that patients and carers play, alongside their own, and the factors that impinge on them. Skilled on-going assessment is central to this, as well as the requirement for the specialist nurse to adjust his or her own roles and behaviours in line with this assessment, as preference and capability fluctuate.
Self-management support was enacted on a continuum of self-management behaviours. The enactment of behaviours was dependent upon where the interpretation of responsibility lay. This required an assessment (by the healthcare professional) of competencies held by the patient and carer. It was also dependent upon the acceptance (or not) of choice by the individual patient and/or carer, as well as the acceptance (or not) of risk by these individuals, and a degree of transfer of risk from the professional. The authors gratefully acknowledge and thank all the study participants (patients, carers and healthcare professionals). Without their participation the study would not have been possible.
Department of Health Disclaimer:
The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health. Wide range of potential information sources GPs, nurses, pharmacists, the package inserts, the internet etc.
Patients did not report any contradictions in information given from the various sources but they reported fears being generated from the package inserts and the internet Organising Number and various forms of medicines prescribed within analgesic regimes (for regular and as needed use), including patches and liquids as well as pills precludes orderly arrangement
Orderly arrangement of numerous and various medicines at home can be difficult for many, preventing medicines from being easily remembered and kept track of Requires individuals to set up their own organisational strategies e.g. plastic boxes/tubs, cupboards, stacks of drawers Wide range of individual strategies are used, which are not always orderly to allow stock levels to be monitored etc.
Filling of a dosette box; lack of clarity for patients about who does this and which medicines can go in it. With supplies of pharmacy-filled dosette boxes e.g. NOMAD, the usual arrangement made is for opioids not to be dispensed in the boxes because of the likelihood of prescription changes
Where individuals purchase a dosette box and self-fill it they may not know which medications are suitable to be stored in it. Individuals have to remember to take their opioids in addition to the medicines in their dosette box.
Storing
Need to put medicines safely away, particularly from grandchildren; safe storage is often not addressed by specialists
Medications are not always stored in the safest location e.g. difficulties in shared accommodation " medicines; many had relatively large supplies of outdated (but not expired) prescription medications These stores can add to the complexity for patients and they may not be able to return them to a pharmacy for disposal
Scheduling
Scheduling medicines according to the best time to take them in Lack of review may lead to appropriate forms and routes of medicines, resulting in less than adequate medicine taking and poorly controlled symptoms
